Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient. Day GS, Gordon BA, Bucelli RC, Perrin RJ, et al. J Neuroimmunol 2021;352:577474.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Day GS, Gordon BA, Bucelli RC, Perrin RJ, et al. Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient. J Neuroimmunol 2021;352:577474.
PMID: 33461093